More on PCRX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $25.50 |
|
|||
| Open | $25.55 | ||||
| 52 Wk High | $80.25 | ||||
| 52 Wk Low | $30.25 | ||||
| Day High | $25.55 | ||||
| Day Low | $24.90 | ||||
| P/E | N/A | ||||
| EPS | $-2.08 | ||||
| Volume | 365,209 | ||||
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PharmaCorp Closes Previously Announced Eight-Store Acquisition and Provides Acquisition Pipeline Update
- UnitedHealthcare to separately reimburse Pacira's EXPAREL drug
- Pacira BioSciences Announces UnitedHealthcare Now Provides Separate Reimbursement for EXPAREL®
- H.C. Wainwright Reiterates Buy Rating on Pacira Pharmaceuticals (PCRX)
- Form 8-K Pacira BioSciences, Inc. For: Jun 28
- Pacira BioSciences to sell iovera° unit to Zimmer Biomet for up to $140M
- Pacira BioSciences Announces Agreement to Divest its iovera° Business to Zimmer Biomet
- Form 4 Pacira BioSciences, Inc. For: Jun 10 Filed by: Hirawat Samit
- Form 4 Pacira BioSciences, Inc. For: Jun 11 Filed by: RIKER LAUREN
Entities mentioned with PCRX
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Stock Buyback | View Related Stories »
- Jefferies & Co | View Related Stories »
- Show More...
